Emzor Pharmaceutical Attains Milestone with Successful Repayment of Commercial Paper
Emzor Pharmaceutical Industries Ltd has successfully repaid its inaugural Series 1 Commercial Paper, attaining a significant milestone in the company’s capital markets journey.
The repayment of the ₦5.13 billion note, which matured on August 18, 2025, demonstrates Emzor’s financial discipline and credibility in Nigeria’s investment landscape.
Emzor is committed to driving innovation and quality in pharmaceutical manufacturing.
The company’s $23 million investment in a state-of-the-art API plant in Sagamu, Ogun State, is expected to enhance Nigeria’s drug self-sufficiency and reduce production costs.
With over 90% of civil engineering works completed and critical production equipment installed, the plant is nearing completion.
Emzor has implemented advanced track-and-trace technology to ensure drug safety and quality.
The company’s ERP system and software solutions support lean manufacturing, tighten inventory management, and strengthen market surveillance, helping to eliminate substandard and counterfeit medications.
Emzor is a leading player in the West African pharmaceutical industry, with a strong presence in Nigeria and exports to countries such as Liberia and Sierra Leone.
The company’s commitment to regional outreach and partnerships has earned it recognition as a pivotal player in enhancing medicine security across the continent.
Emzor commends the Nigerian government’s policies aimed at promoting local pharmaceutical production.
The exemption of pharmaceutical raw materials from import duties and VAT for two years is expected to stimulate local production and make essential medicines more affordable.
Emzor Pharmaceutical’s successful repayment of its commercial paper and commitment to local manufacturing, drug safety, and regional outreach demonstrate its leadership in Nigeria’s pharmaceutical industry.
With its landmark API facility nearing completion, Emzor is poised to continue playing a significant role in building a resilient and accessible healthcare system in Nigeria and beyond.